Interest Paid, Excluding Capitalized Interest, Operating Activities of Vistagen Therapeutics, Inc. from 31 Mar 2021 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary: Vistagen Therapeutics, Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Mar 2021 to 30 Jun 2025.
Vistagen Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Jun 2025 was $6,000.
Vistagen Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $300, a 98% decline from 2020.
Source SEC data: View on sec.gov

Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)

Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)

Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

Vistagen Therapeutics, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025		$6,000	+$6,000		01 Apr 2025	30 Jun 2025	10-Q	07 Aug 2025	2026	Q1
Q2 2024		$0			01 Apr 2024	30 Jun 2024	10-Q	07 Aug 2025	2026	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2021	$300	-$13,000	-98%	01 Apr 2021	31 Mar 2022	10-K	23 Jun 2022	2022	FY
2020	$13,300			01 Apr 2020	31 Mar 2021	10-K	23 Jun 2022	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.